ST
AMRX icon

Smithfield Trust’s Amneal Pharmaceuticals AMRX Stock Holding History

Smithfield Trust’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-125
Closed – – 945
2019
Q3 		$0 Hold
125
– – ﹤0.01% 994
2019
Q2 		$1K Hold
125
– – ﹤0.01% 955
2019
Q1 		$2K Hold
125
– – ﹤0.01% 883
2018
Q4 		$2K Hold
125
– – ﹤0.01% 864
2018
Q3 		$3K Hold
125
– – ﹤0.01% 879
2018
Q2 		$2K Buy
+125
New +$2.19K ﹤0.01% 960

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smithfield Trust's AMRX Position: Q4 2019 in Review

Smithfield Trust sold out of Amneal Pharmaceuticals (AMRX) in Q4 2019, closing a stake of 125 shares.

Smithfield Trust first reported a position in AMRX in Q2 2018 and held it in 6 quarters. The position peaked at $3K in Q3 2018. 129 funds tracked by Wall St. Rank hold AMRX as of Q4 2019.

  • Smithfield Trust reported no remaining Amneal Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Smithfield Trust sold 125 Amneal Pharmaceuticals shares in Q4 2019.
  • Smithfield Trust first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 6 quarters.
  • Smithfield Trust's Amneal Pharmaceuticals position peaked at $3K in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2019.

Based on Smithfield Trust's 13F filing for Q4 2019, filed 13 Feb 2020.